ALG9 (ALG9 alpha-1,2-mannosyltransferase)

2014-11-01  

Identity

HGNC
LOCATION
11q23.1
LOCUSID
ALIAS
CDG1L,DIBD1,GIKANIS,LOH11CR1J
FUSION GENES

Other Information

Locus ID:

NCBI: 79796
MIM: 606941
HGNC: 15672
Ensembl: ENSG00000086848

Variants:

dbSNP: 79796
ClinVar: 79796
TCGA: ENSG00000086848
COSMIC: ALG9

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000086848ENST00000398006Q9H6U8
ENSG00000086848ENST00000524671H0YEX8
ENSG00000086848ENST00000525910H0YF48
ENSG00000086848ENST00000531154Q9H6U8
ENSG00000086848ENST00000532425H0YCW6
ENSG00000086848ENST00000612489A0A087WTZ3
ENSG00000086848ENST00000613181A0A087WVC0
ENSG00000086848ENST00000614444Q9H6U8
ENSG00000086848ENST00000616540Q9H6U8
ENSG00000086848ENST00000618252A0A087WZY8
ENSG00000086848ENST00000619129A0A087WX16

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
N-Glycan biosynthesisKEGGko00510
N-Glycan biosynthesisKEGGhsa00510
Metabolic pathwaysKEGGhsa01100
N-glycan precursor biosynthesisKEGGhsa_M00055
N-glycan precursor biosynthesisKEGGM00055
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
Asparagine N-linked glycosylationREACTOMER-HSA-446203
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent proteinREACTOMER-HSA-446193

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
377618952023Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.0
377618952023Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.0
358396002022Missense variant c.1460 T > C (p.L487P) enhances protein degradation of ER mannosyltransferase ALG9 in two new ALG9-CDG patients presenting with West syndrome and review of the literature.3
358396002022Missense variant c.1460 T > C (p.L487P) enhances protein degradation of ER mannosyltransferase ALG9 in two new ALG9-CDG patients presenting with West syndrome and review of the literature.3
323590332020LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.22
323590332020LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.22
313956172019ALG9 Mutation Carriers Develop Kidney and Liver Cysts.56
313956172019ALG9 Mutation Carriers Develop Kidney and Liver Cysts.56
259666382016A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9.13
267332892016Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.21
259666382016A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9.13
267332892016Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.21
194515482009Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient.10
194515482009Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient.10
168595512006Common variations in ALG9 are not associated with bipolar I disorder: a family-based study.2

Citation

Dessen P

ALG9 (ALG9 alpha-1,2-mannosyltransferase)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/60256/favicon/gene-fusions/js/lib/jquery-3.5.1.min.js